Haibin Deng

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsMedical biochemistry - lipidsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Duo Xu, Yanyun Gao, Shengchen Liu

|Mar 17, 2025
Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer.

Haibin Deng, Liang Zhao, Huixiang Ge

|Dec 06, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer.

Liang Zhao, Haibin Deng, Jingyi Zhang

|Oct 14, 2022
Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma.

Darya Karatkevich, Haibin Deng, Yanyun Gao

Pageof 1

Frequent Collaborators

5 joint publications

Ren-Wang Peng

3 joint publications

Patrick Dorn

3 joint publications

Thomas Michael Marti

3 joint publications

Duo Xu